SMMT
SMMT
NASDAQ · Biotechnology

Summit Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$16.90
-0.95 (-5.32%)
As of Sep 21, 9:45 PM ET ·
Analyst Consensus
Buy
24
Analysts
High
Coverage
Buy 16 67%
Hold 8 33%
Sell 0 0%
Price Target
Analyst Price Target +1,060.2% upside
Low Target $141.53
Average Target $196.08
High Target $244.39
Current Price $16.90
Current
$16.90
Target
$196.08
$141.53 $196.08 avg $244.39
Scenario Analysis
Bear Case
$141.53
737.5%
Low target
Base Case
$196.08
+1,060.2%
Avg target
Bull Case
$244.39
+1,346.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.23
-42.2% from high
52-Week Low
$12.07
+40.0% from low
50-Day SMA
$16.75
+0.9% vs SMA
200-Day SMA
$20.83
-18.9% vs SMA
RSI (14)
54.0
Neutral
Target vs 52W High
$196.08
+570.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%